UBS Group
REVHU

UBS Group’s Revolution Healthcare Acquisition Corp. SAIL Units REVHU Stock Holding History

UBS Group’s Portfolio REVHU Stock Details REVHU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,551
Closed -$113K – 11766
2022
Q3 		$113K Buy
11,551
+281
+2% +$2.76K ﹤0.01% 5611
2022
Q2 		$110K Buy
11,270
+800
+8% +$7.86K ﹤0.01% 5360
2022
Q1 		$103K Buy
10,470
+657
+7% +$6.46K ﹤0.01% 5898
2021
Q4 		$97K Buy
9,813
+9,400
+2,276% +$93.2K ﹤0.01% 6345
2021
Q3 		$4K Buy
+413
New +$4.11K ﹤0.01% 8751

UBS Group's REVHU Position: Q4 2022 in Review

UBS Group sold out of Revolution Healthcare Acquisition Corp. SAIL Units (REVHU) in Q4 2022, closing a stake of 11,551 shares — an estimated $113K sold.

UBS Group first reported a position in REVHU in Q3 2021 and held it in 5 quarters. The position peaked at $113K in Q3 2022. 0 funds tracked by Wall St. Rank hold REVHU as of Q4 2022.

  • UBS Group reported no remaining Revolution Healthcare Acquisition Corp. SAIL Units position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 11,551 Revolution Healthcare Acquisition Corp. SAIL Units shares in Q4 2022, an estimated $113K.
  • UBS Group first reported a position in Revolution Healthcare Acquisition Corp. SAIL Units in Q3 2021 and held it in 5 quarters.
  • UBS Group's Revolution Healthcare Acquisition Corp. SAIL Units position peaked at $113K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Revolution Healthcare Acquisition Corp. SAIL Units as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.